In vivo inhibition of dipeptide peptidase IV activity by Pro-Pro-diphenyl-phosphonate (prodipine)

Biochemical Pharmacology

Volumn 54, Issue 1, 1997, Pages 173-179

  De Meester, Ingrid ^a   Belyaev, Alexander ^a   Lambeir, Anne Marie ^a   De Meyer, Guido R Y ^a   Van Osselaer, Nancy ^a   Haemers, Achiel ^a   Scharpé, Simon ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Activation antigen cluster CD26; Dipeptidyl peptidase IV; in vivo; Phosphonate; proline; Proteinase inhibitor

Indexed keywords

AMINOPEPTIDASE P; DIPEPTIDE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV; MICROSOMAL AMINOPEPTIDASE; PRODIPINE; PROLYL ENDOPEPTIDASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; AMINOPEPTIDASE; METHIONYL AMINOPEPTIDASE; PIPERIDINE DERIVATIVE; SERINE PROTEINASE; X PRO AMINOPEPTIDASE; X-PRO AMINOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; ANIMAL; BLOOD; ENZYMOLOGY; ISOLATION AND PURIFICATION; KIDNEY CORTEX; LIVER; LUNG; METABOLISM; MONOCYTE; SPLEEN; THYMUS;

AMINOPEPTIDASES; ANIMALS; ANTIGENS, CD26; KIDNEY CORTEX; LIVER; LUNG; MALE; MONOCYTES; PIPERIDINES; RABBITS; SERINE ENDOPEPTIDASES; SPLEEN; THYMUS GLAND;

EID: 0030612395     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00149-4     Document Type: Article

References (52)

1. Kenny A, Booth A, George S, Ingram J, Kershaw D, Wood E and Young A, Dipeptidyl peptidase IV, a kidney brush border serine peptidase. Biochem J 155: 169-182, 1976.
2. McDonald J and Barrett A, Mammalian Proteases. A Glossary and Bibliography; Vol. 2. Exopeptidases 1986. Academic Press, London.
3. Yaron A and Naider F, Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28: 251-256, 1993.
4. Vanhoof G, Goossens F, De Meester I, Hendriks D and Scharpé S, Proline motifs in peptides and their biological processing. FASEB J 9: 736-744, 1995.
5. Vanhoof G, De Meester I, van Sande M, Scharpé S and Yaron A, Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur J Clin Chem Clin Biochem 30: 333-338, 1992.
6. Stein H, Schwarting R and Niedobitek G, A2 cluster report: CD 26. In: Leucocyte Typing IV (Eds. Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, von dem Borne AEGKr), pp. 412-415. Oxford University Press, New York, 1989.
7. Fleisher B, CD26: A surface protease involved in T-cell activation. Immunol Today 15: 180-184, 1994.
8. Vanham G, Kestens L, De Meester I, Vingerhoets J, Penne G, Vanhoof G, Scharpé S, Heyligen H, Bosnians E, Ceuppens J and Gigase P, Decreased expression of the memory marker CD26 on both CD4(+) and CD8(+) T lymphocytes of HIV infected subjects. J AIDS 6: 749-757, 1993.
9. Kameoka J, Tanaka T, Nojima Y, Schlossman SF and Morimoto C, Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261: 466-469, 1993.
10. De Meester I, Vanham G, Kestens L, Vanhoof G, Bosmans E, Gigase P and Scharpé S, Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur J Immunol 24: 566-570, 1994.
11. Bednarczyk J, Carroll S, Marin C and McIntyre BW, Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J Cell Biochem 46: 206-218, 1991.
12. Dang NH, Torimoto Y, Deusch K, Schlossman SF and Morimoto C, Comitogenic effect of solid phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol 144: 4092-4100, 1990.
13. De Meester I, Kestens L, Vanham G, Vanhoof G, Vingerhoets J, Gigase P and Scharpé S, Costimulation of CD4+ and CD8+ T cells through CD26: The ADA-binding epitope is not essential for complete signaling. J Leukoc Biol 58: 325-330, 1995.
14. Schön E, Sigbert J, Kiessig ST, Demuth HU, Neubert K, Barth A, Von Baehr R and Ansorge S, The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 17: 1821-1826, 1987.
15. Flentke GR, Munoz E, Huber BT, Plaut AG, Kettner CA and Bachovchin WW, Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Proc Natl Acad Sci USA 88: 1556-1559, 1991.
16. Reinhold D, Bank U, Bühling F, Neubert K, Mattern T, Ulmer AJ, Flad H-D and Ansorge S, Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. Immunobiology 188: 403-414, 1993.
17. Tanaka T, Kameoka J, Yaron A, Schlossman SF and Morimoto C, The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90: 4586-4590, 1993.
18. Tanaka T, Duke-Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF and Morimoto C, Enhancement of antigen-induced T-cell proliferation by soluble CD26/ dipeptidyl peptidase IV. Proc Natl Acad Sci USA 91: 3082-3086, 1994.
19. Hegen M, Mittrucker H-W, Hug R, Demuth H-U, Neubert K, Barth A and Fleischer B, Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not reguired for its signalling function in T cells. Immunobiology 189: 483-493, 1993.
20. Steeg C, Hartwig U and Fleischer B, Unchanged signaling capacity of mutant CD26/dipeptidyl peptidase IV molecules devoid of enzymatic activity. Cell Immunol 164: 311-315, 1995.
21. Coburn M, Hixson D and Reichner J, In vitro immune responsiveness of rats lacking active dipeptidyl peptidase IV. Cell Immunol 158: 269-280, 1994.
22. Bühling F, Kunz D, Reinhold D, Ulmer AJ, Ernst M, Flad HD and Ansorge S, Expression and functional role of dipeptidyl peptidase IV on human natural killer cells. Nat Immunol 13: 270-279, 1996.
23. Bühling F, Junker U, Reinhold D, Neubert K, Jäger L and Ansorge S, Functional role of CD26 on human B lymphocytes. Immunol Lett 45: 47-51, 1995.
24. Laouar A and Bauvois B, Characterization and modulation of cell surface proteases on human myeloblastic (HL-60) cells and comparison to normal myeloid cells. Immunol Lett 34: 257-266, 1992.
25. Nausch I and Heymann E, Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase. J Neurochem 44: 1354-1357, 1985.
26. Ahmad S, Wang L and Ward PE, Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo. J Pharmacol Exp Ther 260: 1257-1261, 1992.
27. Mentlein R, Dahms P, Grandt D and Kruger R, Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pep 49: 133-144, 1993.
28. Mentlein R, Gallwitz B and Schmidt W, Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214: 829-835, 1993.
29. Frohman L, Downs T, Heimer E and Felix A, Dipeptidyl peptidase IV and trypsin-like enzymatic degradation of human growth hormone releasing hormone in plasma. J Clin Invest 83: 1533-1540, 1989.
30. Kieffer T, McIntosh C and Pederson R, Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596, 1995.
31. Morita A, Chung Y, Freeman H, Erickson R, Sleisenger M and Kim Y, Intestinal assimilation of a proline-containing tetrapeptide. J Clin Invest 72: 610-616, 1983.
32. Tirrupathi C, Miyamoto Y, Ganapathy V, Roesel R, Whitford G and Leibach F, Hydrolysis and transport of proline-containing peptides in renal brush border membrane vesicles from dipeptidyl pepbdase IV positive and dipeptidyl peptidase IV negative rat strains. J Biol Chem 265: 1476-1483, 1990.
33. Bauvois B, A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV. Biochem J 252: 723-731, 1988.
34. Hanski C, Hukle T and Reutter W, Involvement of plasma membrane DPP IV in fibronectin-mediated adhesion of cells on collagen. Biol Chem Hoppe-Seyler 366: 1169-1176, 1985.
35. Piazza G, Callanan H, Mowery J and Hixson D, Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J 262: 327-334, 1989.
36. Dang NH, Torimoto Y, Schlossman SF, Morimoto C and Human CD4 helper T cell activation: Functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J Exp Med 172: 649-652, 1990.
37. Fleisher B, Dipeptidyl Peptidase IV (CD26) in Metabolism and the Immune Response. R. G. Landes Company, Austin, TX, 1995.
38. Demuth HU, Baumgrass R, Schaper C, Fischer G and Barth A, Dipeptidyl peptidase IV - Inactivation with N peptidyl-O-aroyl hydroxylamines. J Enzyme Inhibit 2: 129-142, 1988.
39. Borloo M, Augustyns K, Belyaev A, De Meester I, Lambeir A-M, Goossens F, Bollaett W, Rajan P, Scharpé S and Haemers A, Synthesis and evaluation of azaproline peptides as potential inhibitors of dipeptidyl peptidase IV and prolyl oligopeptidase. Lett Pept Sci 2: 198-202, 1995.
40. Li J, Wilk E and Wilk S, Aminoacylpyrrolidine-2-nitriles: Potent and stable inhibitors of dipeptidyl peptidase IV (CD26). Arch Biochem Biophys 323: 148-154, 1995.
41. Chung AY, Ryan JW, Berryer P and Rogoff MA, Xaa-Pro phosphonate diphenyl esters inhibit dipeptidyl peptidase IV. FASEB J 6: A990, 1992.
42. Boduszek B, Oleksyszyn J, Kam CM, Selzler J, Smith R and Powers J, Dipeptide phosphonates as inhibitors of dipeptidyl peptidase IV. J Med Chem 37: 3969-3976, 1994.
43. Lambeir AM, Borloo M, De Meester I, Belyaev A, Augustyns K, Hendriks D, Scharpé S and Haemers A, Dipeptide-derived diphenyl phosphonate esters: Mechanism-based inhibitors of dipeptidyl peptidase IV. Biochim Biophys Acta 1290: 76-82, 1996.
44. Kubota T, Flentke G, Bachovchin W and Stollar B, Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin Exp Immunol 89: 192-197, 1992.
45. Belyaev A, Borloo M, Augustyns K, Lambeir AM, De Meester I, Scharpé S, Blaton N, Peeters O, De Ranter C and Haemers A, A new synthetic method for proline diphenyl phosphonates. Tetrahedron Lett 36: 3755-3758, 1995.
46. Scharpé S, De Meester I, Vanhoof G, Hendriks D, van Sande M, Van Camp K and Yaron A, Assay of dipeptidyl peptidase IV in serum by fluorimetry of 4-methoxy-2-naphthylamine. Clin Chem 34: 2299-2301, 1988.
47. Goossens F, De Meester I, Vanhoof G, Scharpé S, Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. Eur J Clin Chem Clin Biochem 34: 17-22, 1996.
48. De Meester I, Vanhoof G, Lambeir AM and Scharpé S, Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5). J Immunol Methods 189: 99-105, 1996.
49. Schrader W and Stacy A, Purification and subunit structure of adenosine deaminase from human kidney. J Biol Chem 252: 6409-6415, 1977.
50. Bradford M, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
51. Hewitt C, Innes D, Savory J and Wills MR, Normal biochemical and hematological values in New Zealand white rabbits. Clin Chem 35: 1777-1779, 1989.
52. Unger T, Ganten D and Lang R, Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. J Cardiovosc Pharmacol 8(Suppl 110): S75-S81, 1986.